Improved plaque assay identifies a novel anti-Chlamydia ceramide derivative with altered intracellular localization

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 9, 2014, Pages 5537-5546

  Banhart, Sebastian ^a   Saied, Essa M ^b,c   Martini, Andrea ^a   Koch, Sophia ^a   Aeberhard, Lukas ^a,d   Madela, Kazimierz ^a   Arenz, Christoph ^b   Heuer, Dagmar ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c Suez Canal University   (Egypt)

^d MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 O METHYL NITROBENZOXADIAZOLE CERAMIDE C 16; ANTIBIOTIC AGENT; CERAMIDE DERIVATIVE; CHAPERONIN 60; CHLORAMPHENICOL; LACTATE DEHYDROGENASE; NITROBENZOXADIAZOLE CERAMIDE C 16; OXADIAZOLE DERIVATIVE; SPHINGOLIPID; TRICYCLO[4.3.0.1]DECAN 9 YL XANTHOGENATE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CERAMIDE;

AGAR DIFFUSION; ARTICLE; BACTERIAL GROWTH; BACTERIUM CULTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; CHLAMYDIA TRACHOMATIS; CLONAL VARIATION; CONTROLLED STUDY; CYTOTOXICITY ASSAY; DRUG CYTOTOXICITY; DRUG IDENTIFICATION; FEMALE; FLUORESCENCE MICROSCOPY; GENOTYPE; HELA CELL LINE; HUMAN; HUMAN CELL; IC 50; IMMUNODETECTION; IMMUNOFLUORESCENCE; INTRACELLULAR BACTERIUM; LIMIT OF QUANTITATION; LIQUID CULTURE; LIQUID OVERLAY MEDIUM BASED PLAQUE ASSAY; NONHUMAN; PRIORITY JOURNAL; TIME LAPSE IMAGING; ANIMAL; CHLAMYDIA INFECTIONS; DRUG DEVELOPMENT; DRUG EFFECTS; LABORATORY TEST; METABOLISM; MICROBIAL SENSITIVITY TEST; MOUSE; PROCEDURES; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CERAMIDES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CLINICAL LABORATORY TECHNIQUES; DRUG DISCOVERY; HELA CELLS; HUMANS; MICE; MICROBIAL SENSITIVITY TESTS; SPHINGOLIPIDS;

EID: 84906082140     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03457-14     Document Type: Article

References (35)

1. Balabanova Y, Gilsdorf A, Buda S, Burger R, Eckmanns T, Gärtner B, Gross U, Haas W, Hamouda O, Hübner J, Jänisch Kist TM, Kramer MH, Ledig T, Mielke M, Pulz M, Stark K, Suttorp N, Ulbrich U, Wichmann O, Krause G. 2011. Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011. PLoS One 6:e25691. http://dx.doi.org/10.1371/journal.pone.0025691.
2. Haggerty CL, Gottlieb SL, Taylor BD, Low N, Xu F, Ness RB. 2010. Risk of sequelae after Chlamydia trachomatis genital infection in women. J. Infect. Dis. 201(Suppl):S134-S155. http://dx.doi.org/10.1086/652395.
3. Sweet RL, Schachter J, Robbie MO. 1983. Failure of beta-lactam antibiotics to eradicate Chlamydia trachomatis in the endometrium despite apparent clinical cure of acute salpingitis. JAMA 250:2641-2645. http://dx.doi.org/10.1001/jama.1983.03340190043029. (Pubitemid 14225133)
4. Augenbraun M, Bachmann L, Wallace T, Dubouchet L, McCormack W, Hook EW. 1998. Compliance with doxycycline therapy in sexually transmitted diseases clinics. Sex. Transm. Dis. 25:1-4. http://dx.doi.org/10.1097/00007435-199801000- 00001. (Pubitemid 28023761)
5. Dean D, Suchland RJ, Stamm WE. 2000. Evidence for long-term cervical persistence of Chlamydia trachomatis by omp1 genotyping. J. Infect. Dis. 182:909-916. http://dx.doi.org/10.1086/315778.
6. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P. 2004. Chlamydial persistence: beyond the biphasic paradigm. Infect. Immun. 72:1843-1855. http://dx.doi.org/10.1128/IAI.72.4.1843-1855.2004. (Pubitemid 38419894)
7. Bhengraj AR, Vardhan H, Srivastava P, Salhan S, Mittal A. 2010. Decreased susceptibility to azithromycin and doxycycline in clinical isolates of Chlamydia trachomatis obtained from recurrently infected female patients in India. Chemotherapy 56:371-377. http://dx.doi.org/10.1159/000314998.
8. Bastidas RJ, Elwell CA, Engel JN, Valdivia RH. 2013. Chlamydial intracellular survival strategies. Cold Spring Harb. Perspect. Med. 3:a010256. http://dx.doi.org/10.1101/cshperspect.a010256.
9. van Ooij C, Kalman L, Van Ijzendoorn S, Nishijima M, Hanada K, Mostov K, Engel JN. 2000. Host cell-derived sphingolipids are required for the intracellular growth of Chlamydia trachomatis. Cell. Microbiol. 2:627-637. http://dx.doi.org/10.1046/j.1462-5822.2000.00077.x. (Pubitemid 32049331)
10. Ullman MD, Radin NS. 1974. The enzymatic formation of sphingomyelin from ceramide and lecithin in mouse liver. J. Biol. Chem. 249:1506-1512.
11. Hanada K, Kumagai K, Yasuda S, Miura Y, Kawano M, Fukasawa M, Nishijima M. 2003. Molecular machinery for non-vesicular trafficking of ceramide. Nature 426:803-809. http://dx.doi.org/10.1038/nature02188. (Pubitemid 38056858)
12. Hullin-Matsuda F, Taguchi T, Greimel P, Kobayashi T. 2014. Lipid compartmentalization in the endosome system. Semin. Cell Dev. Biol. 31C:48-56. http://dx.doi.org/10.1016/j.semcdb.2014.04.010.
13. Hackstadt T, Rockey DD, Heinzen RA, Scidmore MA. 1996. Chlamydia trachomatis interrupts an exocytic pathway to acquire endogenously synthesized sphingomyelin in transit from the Golgi apparatus to the plasma membrane. EMBO J. 15:964-977. (Pubitemid 26077824)
14. Scidmore MA, Fischer ER, Hackstadt T. 2003. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect. Immun. 71:973-984. http://dx.doi.org/10.1128/IAI. 71.2.973-984.2003. (Pubitemid 36150794)
15. Heuer D, Rejman Lipinski A, Machuy N, Karlas A, Wehrens A, Siedler F, Brinkmann V, Meyer TF. 2009. Chlamydia causes fragmentation of the Golgi compartment to ensure reproduction. Nature 457:731-735. http://dx.doi.org/10. 1038/nature07578.
16. Rejman Lipinski A, Heymann J, Meissner C, Karlas A, Brinkmann V, Meyer TF, Heuer D. 2009. Rab6 and Rab11 regulate Chlamydia trachomatis development and golgin-84-dependent Golgi fragmentation. PLoS Pathog. 5:e1000615. http://dx.doi.org/10.1371/journal.ppat.1000615.
17. Elwell CA, Jiang S, Kim JH, Lee A, Wittmann T, Hanada K, Melancon P, Engel JN. 2011. Chlamydia trachomatis co-opts gbf1 and cert to acquire host sphingomyelin for distinct roles during intracellular development. PLoS Pathog. 7:e1002198. http://dx.doi.org/10.1371/journal.ppat.1002198.
18. Derre I, Swiss R, Agaisse H. 2011. The lipid transfer protein CERT interacts with the Chlamydia inclusion protein IncD and participates to ER-Chlamydia inclusion membrane contact sites. PLoS Pathog. 7:e1002092. http://dx.doi.org/10.1371/journal.ppat.1002092.
19. Matsumoto A, Izutsu H, Miyashita N, Ohuchi M. 1998. Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma. J. Clin. Microbiol. 36:3013-3019. (Pubitemid 28429430)
20. Gieffers J, Belland RJ, Whitmire W, Ouellette S, Crane D, Maass M, Byrne GI, Caldwell HD. 2002. Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay. Infect. Immun. 70:5827-5834. http://dx.doi.org/10.1128/IAI. 70.10.5827-5834.2002.
21. Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Preibisch S, Rueden C, Saalfeld S, Schmid B, Tinevez J-Y, White DJ, Hartenstein V, Eliceiri K, Tomancak P, Cardona A. 2012. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9:676-682. http://dx.doi.org/10.1038/nmeth.2019.
22. Bhabak KP, Hauser A, Redmer S, Banhart S, Heuer D, Arenz C. 2013. Development of a novel FRET probe for the real-time determination of ceramidase activity. ChemBioChem 14:1049-1052. http://dx.doi.org/10.1002/cbic.201300207.
23. Heuer D, Brinkmann V, Meyer TF, Szczepek AJ. 2003. Expression and translocation of chlamydial protease during acute and persistent infection of the epithelial HEp-2 cells with Chlamydophila (Chlamydia) pneumoniae. Cell. Microbiol. 5:315-322. http://dx.doi.org/10.1046/j.1462-5822.2003.00278.x. (Pubitemid 37009909)
24. Belland RJ, Scidmore MA, Crane DD, Hogan DM, Whitmire W, McClarty G, Caldwell HD. 2001. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes. Proc. Natl. Acad. Sci. U. S. A. 98:13984-13989. http://dx.doi.org/10.1073/pnas.241377698. (Pubitemid 33116010)
25. Tipples G, McClarty G. 1993. The obligate intracellular bacterium Chlamydia trachomatis is auxotrophic for three of the four ribonucleoside triphosphates. Mol. Microbiol. 8:1105-1114. http://dx.doi.org/10.1111/j.1365- 2958.1993.tb01655.x. (Pubitemid 23187029)
26. Adibhatla RM, Hatcher JF, Gusain A. 2012. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: amini-review of literature. Neurochem. Res. 37:671-679. http://dx.doi.org/10.1007/s11064-011-0659-z.
27. Pütz U, Schwarzmann G. 1995. Golgi staining by two fluorescent ceramide analogues in cultured fibroblasts requires metabolism. Eur. J. Cell Biol. 68:113-121.
28. Matrosovich M, Matrosovich T, Garten W, Klenk H-D. 2006. New low-viscosity overlay medium for viral plaque assays. Virol. J. 3:63. http://dx.doi.org/10.1186/1743-422X-3-63.
29. Banks J, Eddie B, Sung M, Sugg N, Schachter J, Meyer KF. 1970. Plaque reduction technique for demonstrating neutralizing antibodies for Chlamydia. Infect. Immun. 2:443-447.
30. Hobson D, Stefanidis D, Rees E, Tait IA. 1982. Effects of chloramphenicol on Chlamydia trachomatis infection in neonatal conjunctivitis and in McCoy cell cultures. J. Hyg. 89:457-466. http://dx.doi.org/10.1017/S0022172400071023. (Pubitemid 13151385)
31. de Melo EJ, de Souza W. 1996. Pathway of C6-NBD-Ceramide on the host cell infected with Toxoplasma gondii. Cell Struct. Funct. 21:47-52. http://dx.doi.org/10.1247/csf.21.47.
32. Huitema K, van den Dikkenberg J, Brouwers JFHM, Holthuis JCM. 2004. Identification of a family of animal sphingomyelin synthases.EMBO J. 23:33-44. http://dx.doi.org/10.1038/sj.emboj.7600034. (Pubitemid 38165745)
33. Kuhle V, Abrahams GL, Hensel M. 2006. Intracellular Salmonella enterica redirect exocytic transport processes in a Salmonella pathogenicity island 2-dependent manner. Traffic 7:716-730. http://dx.doi.org/10.1111/j.1600-0854. 2006.00422.x. (Pubitemid 43676979)
34. Lipsky NG, Pagano RE. 1985. A vital stain for the Golgi apparatus. Science 228:745-747. http://dx.doi.org/10.1126/science.2581316.
35. Hackstadt T, Scidmore MA, Rockey DD. 1995. Lipid metabolism in Chlamydia trachomatis-infected cells: directed trafficking of Golgi-derived sphingolipids to the chlamydial inclusion. Proc. Natl. Acad. Sci. U. S. A. 92:4877-4881. http://dx.doi.org/10.1073/pnas.92.11.4877.